Features of the modern antihistamines use in the treatment of allergic rhinitis

Allergic rhinitis remains one of the most relevant problems of modern otorhinolaryngology. The widespread prevalence, late diagnosis, underestimation of the possible risks of disease progression, the development of complications (including asthma) prompts the development and improvement of new treat...

Full description

Bibliographic Details
Main Authors: A. A. Krivopalov, S. A. Rebrova, P. A. Shamkina
Format: Article
Language:Russian
Published: Remedium Group LLC 2021-09-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/6336
_version_ 1797842184732409856
author A. A. Krivopalov
S. A. Rebrova
P. A. Shamkina
author_facet A. A. Krivopalov
S. A. Rebrova
P. A. Shamkina
author_sort A. A. Krivopalov
collection DOAJ
description Allergic rhinitis remains one of the most relevant problems of modern otorhinolaryngology. The widespread prevalence, late diagnosis, underestimation of the possible risks of disease progression, the development of complications (including asthma) prompts the development and improvement of new treatment options for allergic rhinitis. Allergic rhinitis is a heterogeneous disease that presents with various clinical phenotypes, and therefore the severity of nasal symptoms can vary from mild malaise to severe disease.. Today, pharmacotherapy remains the most frequently used treatment tactic for patients with allergic rhinitis. While prescribing therapy the doctor develops an individual treatment plan based on the principles of personalized medicine, considering: the dominant symptoms, anamnesis data on previous therapy and the effect of treatment, the type of inflammation (Th2-type, mixed inflammation), concomitant diseases (conjunctivitis, asthma, etc.) etc.) and patient preferences. The tissue effects of the histamine mediator lead to the development of symptoms during the course of the disease, which determines the wide-spread use of antihistamines in the treatment of rhinitis. Antihistamines of the second generation are devoid of sedative effects, have a long-lasting effect and a good safety profile. One of the modern II generation antihistamines is bilastine. The research results proved the high antihistaminic activity of bilastine 20 mg in vitro and in vivo, the absence of cardiac and sedative side effects on the central nervous system, the ability to eliminate the nasal and ocular symptoms of disease and improve the quality of life of patients with allergic rhinitis. Thus, bilastine fully complies with current EAACI / WAO ARIA requirements for drugs used to treat AR. The paper presents a clinical case of a patient with chronic persistent allergic rhinitis, household sensitization with a slight uncontrolled course. The oral antihistamine bilastine was added to intranasal glucocorticosteroids, which help to relieve symptoms of the disease, stabilize the condition and prepare the patient for subsequent allergen-specific immunotherapy.
first_indexed 2024-04-09T16:43:42Z
format Article
id doaj.art-96059ec627524b09a113bae78e183e2b
institution Directory Open Access Journal
issn 2079-701X
2658-5790
language Russian
last_indexed 2024-04-09T16:43:42Z
publishDate 2021-09-01
publisher Remedium Group LLC
record_format Article
series Медицинский совет
spelling doaj.art-96059ec627524b09a113bae78e183e2b2023-04-23T06:56:34ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902021-09-0101210110810.21518/2079-701X-2021-12-101-1085716Features of the modern antihistamines use in the treatment of allergic rhinitisA. A. Krivopalov0S. A. Rebrova1P. A. Shamkina2Saint Petersburg Research Institute of Ear, Throat, Nose and SpeechSaint Petersburg Research Institute of Ear, Throat, Nose and SpeechSaint Petersburg Research Institute of Ear, Throat, Nose and SpeechAllergic rhinitis remains one of the most relevant problems of modern otorhinolaryngology. The widespread prevalence, late diagnosis, underestimation of the possible risks of disease progression, the development of complications (including asthma) prompts the development and improvement of new treatment options for allergic rhinitis. Allergic rhinitis is a heterogeneous disease that presents with various clinical phenotypes, and therefore the severity of nasal symptoms can vary from mild malaise to severe disease.. Today, pharmacotherapy remains the most frequently used treatment tactic for patients with allergic rhinitis. While prescribing therapy the doctor develops an individual treatment plan based on the principles of personalized medicine, considering: the dominant symptoms, anamnesis data on previous therapy and the effect of treatment, the type of inflammation (Th2-type, mixed inflammation), concomitant diseases (conjunctivitis, asthma, etc.) etc.) and patient preferences. The tissue effects of the histamine mediator lead to the development of symptoms during the course of the disease, which determines the wide-spread use of antihistamines in the treatment of rhinitis. Antihistamines of the second generation are devoid of sedative effects, have a long-lasting effect and a good safety profile. One of the modern II generation antihistamines is bilastine. The research results proved the high antihistaminic activity of bilastine 20 mg in vitro and in vivo, the absence of cardiac and sedative side effects on the central nervous system, the ability to eliminate the nasal and ocular symptoms of disease and improve the quality of life of patients with allergic rhinitis. Thus, bilastine fully complies with current EAACI / WAO ARIA requirements for drugs used to treat AR. The paper presents a clinical case of a patient with chronic persistent allergic rhinitis, household sensitization with a slight uncontrolled course. The oral antihistamine bilastine was added to intranasal glucocorticosteroids, which help to relieve symptoms of the disease, stabilize the condition and prepare the patient for subsequent allergen-specific immunotherapy.https://www.med-sovet.pro/jour/article/view/6336allergic diseasesallergic rhinitispharmacotherapyh1-blockerssecond-generation antihistaminesbilastine
spellingShingle A. A. Krivopalov
S. A. Rebrova
P. A. Shamkina
Features of the modern antihistamines use in the treatment of allergic rhinitis
Медицинский совет
allergic diseases
allergic rhinitis
pharmacotherapy
h1-blockers
second-generation antihistamines
bilastine
title Features of the modern antihistamines use in the treatment of allergic rhinitis
title_full Features of the modern antihistamines use in the treatment of allergic rhinitis
title_fullStr Features of the modern antihistamines use in the treatment of allergic rhinitis
title_full_unstemmed Features of the modern antihistamines use in the treatment of allergic rhinitis
title_short Features of the modern antihistamines use in the treatment of allergic rhinitis
title_sort features of the modern antihistamines use in the treatment of allergic rhinitis
topic allergic diseases
allergic rhinitis
pharmacotherapy
h1-blockers
second-generation antihistamines
bilastine
url https://www.med-sovet.pro/jour/article/view/6336
work_keys_str_mv AT aakrivopalov featuresofthemodernantihistaminesuseinthetreatmentofallergicrhinitis
AT sarebrova featuresofthemodernantihistaminesuseinthetreatmentofallergicrhinitis
AT pashamkina featuresofthemodernantihistaminesuseinthetreatmentofallergicrhinitis